|
[1]
|
周军辉, 李静, 王答祺, 等. 披针叶黄华种子中金雀花碱的定性和定量分析[J]. 中草药, 2010, 41(7): 1184-1186.
|
|
[2]
|
Tutka, P. and Zatoński, W. (2006) Cytisine for the Treatment of Nicotine Addiction: From a Molecule to Therapeutic Efficacy. Pharmacological Reports, 58, 777-798 and References Therein.
|
|
[3]
|
Liu, L., Alam, M.S., Hirata, K., Matsuda, K. and Ozoe, Y. (2008) Actions of Quinolizidine Alkaloids on Periplaneta Americana Nicotinic Acetylcholine Receptors. Pest Management Science, 64, 1222-1228. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Coe, J.W. (2000) Total Synthesis of (+/-)-Cytisine via the Intramolecular Heck Cyclization of Activated N-Alkyl Glutarimides. Organic Letters, 2, 4205-4208. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Coe, J.W., Rollema, H. and O’Neill, B.T. (2009) Chapter 4 Case History: Chantix™/Champix™ (Varenicline Tartrate), A Nicotinic Acetylcholine Receptor Partial Agonist as a Smoking Cessation Aid. Annual Reports in Medicinal Chemistry, 44, 71-101. [Google Scholar] [CrossRef]
|
|
[6]
|
Marriere, E., Rouden, J., Tadino, V. and Lasne, M.C. (2000) Synthesis of Analogues of (−)-Cytisine for In Vivo Studies of Nicotinic Receptors Using Positron Emission Tomography. Organic Letters, 2, 1121-1124. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Pérez, E.G., Méndez-Gálvez, C. and Cassels, B.K. (2012) Cytisine: A Natural Product Lead for the Development of Drugs Acting at Nicotinic Acetylcholine Receptors. Natural Product Reports, 29, 555. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Schep, L.J., Slaughter, R.J. and Beasley, D.M.G. (2009) Nicotinic Plant Poisoning. Clinical Toxicology, 47, 771-781. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Rollema, H., Shrikhande, A., Ward, K.M., et al. (2010) Pre-Clinical Properties of the α4β2 Nicotinic Acetylcholine Receptor Partial Agonists Varenicline, Cytisine and Dianicline Translate to Clinical Efficacy for Nicotine Dependence. British Journal of Pharmacology, 160, 334-345. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Gundisch, D. (2000) Nicotinic Acetylcholine Receptors and Imaging. Current Pharmaceutical Design, 6, 1143-1157. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Chandler, C.J. and Stolerman, I.P. (1997) Discriminative Stimulus Properties of the Nicotinic Agonist Cytisine. Psychopharmacology, 129, 257-264. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Pogocki, D., Ruman, T., Danilczuk, M., et al. (2007) Application of Nicotine Enantiomers, Derivatives and Analogues in Therapy of Neuro-degenerative Disorders. European Journal of Pharmacology, 563, 18-39. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
姚秀娟, 李锐松. 野靛碱对离体豚鼠乳头肌的作用[J]. 第四军医大学学报, 1986, 7(1): 39-41.
|
|
[14]
|
王秀坤, 李家实, 闫玉凝. 槐属羽扇豆类生物碱及其药理作用研究概况[J]. 现代药物与临床, 1996(1): 9-14.
|
|
[15]
|
Han, J., Wang, D.-S., Liu, S.-B. and Zhao, M.-G. (2016) Cytisine, a Partial Agonist of α4β2 Nicotinic Acetylcholine Re-ceptors, Reduced Unpredictable Chronic Mild Stress-Induced Depression-Like Behaviors. Biomolecules & Therapeutics, 24, 291-297. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Ferger, B., Spratt, C., Teismann, P., et al. (1998) Effects of Cytisine on Hydroxyl Radicals In Vitro and MPTP-Induced Dopamine Depletion In Vivo. European Journal of Pharmacology, 360, 155-163. [Google Scholar] [CrossRef]
|
|
[17]
|
Abin-Carriquiry, J.A., Costa, G., Urbanavicius, J., et al. (2008) In Vivo Modulation of Dopaminergic Nigrostriatal Pathways by Cytisine Derivatives: Implications for Parkinson’s Disease. European Journal of Pharmacology, 589, 80-84. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Museo, E. and Wise, R.A. (1995) Cyti-sine-Induced Behavioral Activation: Delineation of Neuroanatomical Locus of Action. Brain Research, 670, 257-263. [Google Scholar] [CrossRef]
|
|
[19]
|
Brioni, J.D. and Arneric, S.P. (1993) Nicotinic Receptor Agonists Facilitate Retention of Avoidance Training: Participation of Dopaminergic Mechanisms. Behavioral & Neural Biology, 59, 57-62. [Google Scholar] [CrossRef]
|
|
[20]
|
Sloan, J.W., Martin, W.R., Bostwick, M., et al. (1988) The Comparative Binding Characteristics of Nicotinic Ligands and Their Pharmacology. Pharmacology Biochemistry & Behavior, 30, 255-267. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Decker, M.W., Brioni, J.D., Bannon, A.W. and Arneric, S.P. (1995) Diver-sity of Neuronal Nicotinic Acetylcholine Receptors: Lessons from Behavior and Implications for CNS Therapeutics. Life Sciences, 56, 545-570. [Google Scholar] [CrossRef]
|
|
[22]
|
Yu, L., Jiang, B., Chen, Z., et al. (2018) Cytisine Induces Endoplasmic Reticulum Stress Caused by Calcium Overload in HepG2 Cells. Oncology, 39, 1475-1484.
|
|
[23]
|
黎萍, 杨敏丽. 披针叶黄华中金雀花碱类生物碱的提取工艺[J]. 华西药学杂志, 2007, 22(1): 7-8.
|
|
[24]
|
Sariev, A.K., Zherdev, V.P., Sologova, S.S., et al. (1999) Cytisine Pharmacokinetics When Used in a Transdermal Therapeutic System in Rabbits. Eksperimental’naia i Klinicheskaia Far-makologiia, 62, 59-61. (In Russian)
|
|
[25]
|
Reavill, C., Walther, B., Stolerman, I.P., et al. (1990) Behavioural and Pharmacokinetic Studies on Nicotine, Cytisine and Lobeline. Neuropharmacology, 29, 619-624. [Google Scholar] [CrossRef]
|
|
[26]
|
Klöcking, H.P., Richter, M. and Damm, G. (1980) Pharmacokinetic Studies with 3H-Cytisine. Archives of Toxicology Supplement, 4, 312-314. [Google Scholar] [CrossRef] [PubMed]
|